Sale of 1,844 shares at $72.39 per share.
Reporting Person Boulding Mark Elliott · Officer Title EXEC. VP AND CLO · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001578852-26-000022 · filed 2026-08-19 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "PTC THERAPEUTICS, INC. (PTCT)." Disclosed 2026-08-19. https://desqlong.com/cards/0001578852-26-000022-2 (retrieved 2026-09-26).